Technology | Advanced Visualization | February 27, 2018

ContextVision Demonstrates VolarView and the Orthopedic Package at ECR 2018

VolarView provides image enhancement for handheld ultrasound, Orthopedic package for radiography

ContextVision Demonstrates VolarView and the Orthopedic Package at ECR 2018

February 27, 2018 – At this year’s European Congress of Radiology (ECR), Feb. 28-March 4 in Vienna, Austria, ContextVision will showcase two new products: VolarView for handheld ultrasound devices and the Orthopedic Package for radiography. ContextVision will also hold demonstrations of its imaging enhancement software for 2-D/3-D/4-D ultrasound, X-ray, magnetic resonance imaging (MRI) and mammography for booth visitors.

Showcase products at ECR include:

VolarView – ContextVision’s image enhancement technology is now available also for the handheld ultrasound market segment. VolarView is designed for efficient implementation on all types of handheld devices such as smartphone- and tablet-based systems. The increased availability of handheld devices extends the use of ultrasound to application areas and users beyond the traditional ones. ContextVision now offers intelligent image enhancement technology for the full range of ultrasound systems addressing the growing need for patient care; and

GOPView XR2Plus Orthopedic package – ContextVision’s orthopedic package addresses the specific image quality requirements for orthopedic imaging and facilitates low dose exposures with highest image quality. The superior dynamics of ContextVision’s image enhancement allow system manufacturers to easily meet a wide variety of preferences, according to the company.

The company has made significant upgrades to its product portfolio ofintelligent imaging software. ContextVision also aims to harness its research in artificial intelligence (AI) to advance the radiology industry, improving imaging, diagnoses and patient care.

For more information: www.contextvision.com

 

Related Content

Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cardiac Imaging | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Siemens Healthineers Announces First Installation of Acuson Sequoia Ultrasound
News | Ultrasound Imaging | September 20, 2018
September 20, 2018 — Siemens Healthineers announced the first global installation of its newest...
LVivo EF Cardiac Tool Now Available for GE Vscan Extend Handheld Mobile Ultrasound
Technology | Cardiovascular Ultrasound | September 19, 2018
DiA Imaging Analysis Ltd. (DiA), a provider of artificial intelligence (AI)-powered ultrasound analysis tools,...
Exact Imaging Partners to Improve Prostate Cancer Detection With Artificial Intelligence
News | Prostate Cancer | September 19, 2018
Exact Imaging, makers of the ExactVu micro-ultrasound platform, has partnered with U.K.-based Cambridge Consultants to...
Agfa Brings Intelligent Radiography to RSNA 2018
News | Digital Radiography (DR) | September 17, 2018
September 17, 2018 — At the 2018 Radiological Society of North America (RSNA) annual meeting, Nov.
SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
At RSNA 2018, radiology professionals will discover intelligent radiography powered by MUSICA, at Agfa's booth.

At RSNA 2018, radiology professionals will discover intelligent radiography powered by MUSICA, at Agfa's booth.

News | Digital Radiography (DR) | September 13, 2018
At RSNA 2018, radiology professionals will discover intelligent
The DRX-Transportable System/Lite
News | X-Ray | September 12, 2018
Columbus Regional Health (Columbus, Ind.) has deployed a Carestream ...
Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | September 12, 2018
In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore co